George Greene, Ph.D., associate director of the Evaluation, Data Integration, and Technical Assistance (EDIT) Program in the Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH) and research assistant professor of Medical Social Sciences and Psychiatry and Behavioral Sciences at Northwestern, and Amy K. Johnson, Ph.D., research assistant professor at the Ann and Robert H. Lurie Children’s Hospital of Chicago and director of research, evaluation, and data services at the AIDS Foundation of Chicago (AFC), were recently awarded an HIV Cure Grant through Gilead Sciences Inc. for their community-academic partnership. This partnership will implement the Chicago Unites in Research to End HIV (CURE HIV) Project. Drs. Greene and Johnson are Co-Principal Investigators, and AFC is the lead agency, as well as the primary grant awardee.
The CURE HIV Project seeks to establish foundational knowledge for the development and advancement of a cure research agenda. Investigators will engage communities disproportionately affected by HIV in research to assess their understanding of and interest in HIV cure research. Moreover, they will educate and train community liaisons and HIV cure researchers to increase and sustain dialogue and collaboration among stakeholders. In addition, the CURE HIV Project will host in-person events for both HIV-impacted communities and cure scientists to increase communication, transparency, and engagement, while disseminating data gathered during the project.
Gilead HIV Cure grants are awarded to organizations with a proven record of excellence in results-driven research working in various HIV cure .